APOA1 and coronary artery disorder: As a consequence, higher levels of HNE-protein adducts and lower levels of IgM anti-ApoA-I251–262 HNE, respectively, showed 2.208-fold (p = 0.020, power = 0.938) and 2.046-fold (p = 0.035, power = 0.881) higher risks between CAD patients with <30% versus >30% stenosis, indicating a significant difference after adjustments for age, gender, PCr, and HDL in the logistic regression analyses (Table 3).